7,580.07

-140.32

-1.82%

51,770.31

-572.29

-1.09%

25,437.00

-747.70

-2.86%

2,811.84

-47.38

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,789.28

+265.35

+0.34%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqGS - Delayed Quote USD

PMV Pharmaceuticals, Inc. (PMVP)

1.3100 -0.0400 (-2.96%)

At close: October 30 at 4:00:00 PM EDT

Loading Chart for PMVP

Chart Range Bar

Interval:

In partnership with ChartIQ

PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors

PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Push

PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Push

PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities

PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities

PMV Pharmaceuticals Reports Updated Rezatapopt Ovarian Cancer Data, Commences Offering

PMV Pharmaceuticals Reports Updated Rezatapopt Ovarian Cancer Data, Commences Offering

PMV Pharma Announces Proposed Public Offering of Securities

PMV Pharma Announces Proposed Public Offering of Securities

PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial

PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial

PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights

PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights

PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity

Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity

PMV Pharmaceuticals Announces Board Chair Transition

PMV Pharmaceuticals Announces Board Chair Transition

Mobilize your Website

View Site in Mobile | Classic

Share by: